Català Español Home page UB   
Master's degree courses and postgraduate courses endorsed by the University of Barcelona and University of Barcelona Group

Back

 

 

GENERAL INFORMATION
Name of course :
BIOETHICS AND LAW: HEALTH PROBLEMS AND BIOTECHNOLOGY
Qualification awarded:
Master (Degree Universitat Barcelona)
Number of credits:
50,00
Centre responsible :
Faculty of Law
Length of course (in academic years):
2
Mode of delivery (face-to-face/ blended/ distance):
Blended

MANAGEMENT
Casado González, María

RECOMMENDED APPLICANT PROFILES AND ADMISSION REQUIREMENTS:
Professionals who work in the health care area, jurists, philosophy and humanities teachers, journalists, psychologists, sociologists, educators, and those who work in the communication and education areas.13;
Admission requirements: university degree or diploma.

LEARNING OBJECTIVES:
To acquire a global and holistic view of bioethics and its juridical implications; to receive an interdisciplinary training for dealing with different philosophical, medical and scientific problems as well as those derived from the applications of research, and the way they can be dealt with legally; to know and clarify the main issues of bioethical discourse and examine its ramifications for society as a whole.

FURTHER INFORMATION OF INTEREST
Enrolment fee:
First year:
2.400,00 €
Second year:
2.200,00 €
In-company placement(s):
NO
Pre-enrolment begins:
9/15/2007
Pre-enrolment ends:
9/30/2007
Classes begin:
10/10/2007

CENTRE WHERE THE COURSE IS TAUGHT
Name of Individual or Institution:
Observatori de Bioética i Dret
Address:
Baldiri Reixac,4-6. Torre D 4º
08028 Barcelona
España
Email:
obd@pcb.ub.es
Website:
http://www.bioeticayderecho.ub.es
Telephone:
93.4034546
Fax:
93.4034546

FOR FURTHER ENQUIRIES
Name of Individual or Institution:
Observatori de Bioètica i Dret
Address:
Baldiri Reixac, 4-6. Torre D 4º

08028 Barcelona
España
Email:
obd@pcb.ub.es
Website:
http://www.bioeticayderecho.ub.es
Telephone:
93.4034546
Fax:
93.4034546


Agència de Postgrau - GIGA
Updated: 8/1/2008.